昭衍新药：董事、监事及高管减持A股股份计划公告

Summary of Key Points - The company Zhaoyan New Drug announced a share reduction plan involving several key individuals [2] - The planned reduction will occur from September 30, 2025, to November 28, 2025, through block trading or centralized bidding on the Shanghai Stock Exchange [2] - The total shares to be reduced amount to 848,300, which represents approximately 0.1132% of the company's current total share capital [2]